Source: Eur Respir J, 50 (5) 1701486; 10.1183/13993003.01486-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Arnaud Bourdin, Nicolas Molinari, Isabelle Vachier, Laurie Pahus, Carey Suehs, Pascal Chanez. Mortality: a neglected outcome in OCS-treated severe asthma. Eur Respir J, 50 (5) 1701486; 10.1183/13993003.01486-2017

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics and burden of illness in a cohort of severe asthma patients Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Severe asthma: one disease many definitions Source: International Congress 2019 – Asthma and the world Year: 2019 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020 Year: 2021 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Anaemia in COPD: mortality and disease severity Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Difficult-to-treat asthma: how serious is the problem and what are the issues? Source: Eur Respir Mon 2011; 51: 1-15 Year: 2011 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Obesity in pediatric asthma: prevalence and impact on severity Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Predictors of 90 day readmission in hospitalized patients for asthma exacerbation Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Severe asthma: classification and treatment Source: Virtual Congress 2021 – Clinical year in review Year: 2021